Amada S - Search Results

1

Sentinel node detection with (99m)Tc phytate alone is satisfactory for cervical cancer patients undergoing radical hysterectomy and pelvic lymphadenectomy.

Ogawa S, Kobayashi H, Amada S, Yahata H, Sonoda K, Abe K, Baba S, Sasaki M, Kaku T, Wake N. Ogawa S, et al. Among authors: amada s. Int J Clin Oncol. 2010 Feb;15(1):52-8. doi: 10.1007/s10147-009-0010-8. Epub 2010 Jan 21. Int J Clin Oncol. 2010. PMID: 20087618

2

Postoperative adjuvant chemotherapy with cisplatin, cyclophosphamide, and anthracycline (doxorubicin, epirubicin, pirarubicin) for endometrial cancer.

Yahata H, Hirakawa T, Fujita T, Ariyoshi K, Sonoda K, Amada S, Kobayashi H, Nakano H. Yahata H, et al. Among authors: amada s. Int J Clin Oncol. 2004 Aug;9(4):317-21. doi: 10.1007/s10147-004-0400-x. Int J Clin Oncol. 2004. PMID: 15375709

3

Predicting pelvic lymph node metastasis in endometrial carcinoma.

Kamura T, Yahata H, Shigematsu T, Ogawa S, Amada S, Kaku T, Nakano H. Kamura T, et al. Among authors: amada s. Gynecol Oncol. 1999 Mar;72(3):387-91. doi: 10.1006/gyno.1998.5288. Gynecol Oncol. 1999. PMID: 10053111

4

Increased nuclear localization of transcription factor YB-1 in acquired cisplatin-resistant ovarian cancer.

Yahata H, Kobayashi H, Kamura T, Amada S, Hirakawa T, Kohno K, Kuwano M, Nakano H. Yahata H, et al. Among authors: amada s. J Cancer Res Clin Oncol. 2002 Nov;128(11):621-6. doi: 10.1007/s00432-002-0386-6. Epub 2002 Oct 22. J Cancer Res Clin Oncol. 2002. PMID: 12458343

5

Adenocarcinoma of the uterine cervix with predominantly villogladular papillary growth pattern.

Kaku T, Kamura T, Shigematsu T, Sakai K, Nakanami N, Uehira K, Amada S, Kobayashi H, Saito T, Nakano H. Kaku T, et al. Among authors: amada s. Gynecol Oncol. 1997 Jan;64(1):147-52. doi: 10.1006/gyno.1996.4539. Gynecol Oncol. 1997. PMID: 8995564

6

Early adenocarcinoma of the uterine cervix.

Kaku T, Kamura T, Sakai K, Amada S, Kobayashi H, Shigematsu T, Saito T, Nakano H. Kaku T, et al. Among authors: amada s. Gynecol Oncol. 1997 May;65(2):281-5. doi: 10.1006/gyno.1997.4652. Gynecol Oncol. 1997. PMID: 9159338

7

The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix.

Kaku T, Sonoda K, Kamura T, Hirakawa T, Sakai K, Amada S, Ogawa S, Kobayashi H, Nakashima M, Watanabe T, Nakano H. Kaku T, et al. Among authors: amada s. Clin Cancer Res. 1999 Jun;5(6):1449-53. Clin Cancer Res. 1999. PMID: 10389931

8

The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium.

Sonoda K, Kaku T, Hirakawa T, Kobayashi H, Amada S, Sakai K, Nakashima M, Watanabe T, Nakano H. Sonoda K, et al. Among authors: amada s. Gynecol Oncol. 2000 Dec;79(3):424-9. doi: 10.1006/gyno.2000.5981. Gynecol Oncol. 2000. PMID: 11104614

9

Cytological study of early cervical adenocarcinoma: special reference to the depth of invasion.

Kaku T, Kawano Y, Hirakawa T, Koga Y, Kobayashi H, Amada S, Ogawa S, Hagiwara T, Watanabe S, Nakano H. Kaku T, et al. Among authors: amada s. Cytopathology. 2005 Dec;16(6):290-4. doi: 10.1111/j.1365-2303.2005.00272.x. Cytopathology. 2005. PMID: 16303042

10

Angiogenesis in adenocarcinoma of the uterine cervix.

Kaku T, Hirakawa T, Kamura T, Amada S, Kinukawa N, Kobayashi H, Sakai K, Ariyoshi K, Sonoda K, Nakano H. Kaku T, et al. Among authors: amada s. Cancer. 1998 Oct 1;83(7):1384-90. doi: 10.1002/(sici)1097-0142(19981001)83:7<1384::aid-cncr16>3.0.co;2-0. Cancer. 1998. PMID: 9762940

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters